{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T05:05:55Z","timestamp":1785128755552,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Long noncoding RNAs (lncRNAs) are abnormally expressed in a broad type of cancers and play significant roles that regulate tumor development and metastasis. However, the pathological roles of lncRNAs in esophageal squamous cell carcinoma (ESCC) remain largely unknown. Here we aimed to investigate the role and regulatory mechanism of the novel lncRNA RPL34-AS1 in the development and progression of ESCC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The expression level of RPL34-AS1 in ESCC tissues and cell lines was determined by RT-qPCR. Functional experiments in vitro and in vivo were employed to explore the effects of RPL34-AS1 on tumor growth in ESCC cells. Mechanistically, fluorescence in situ hybridization (FISH), bioinformatics analyses, luciferase reporter assay, RNA immunoprecipitation (RIP) assay and western blot assays were used to detect the regulatory relationship between RPL34-AS1, miR-575 and ACAA2.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>RPL34-AS1 was significantly down-regulated in ESCC tissues and cells, which was negatively correlated with overall survival in ESCC patients. Functionally, upregulation of RPL34-AS1 dramatically suppressed ESCC cell proliferation, colony formation, invasion and migration in vitro, whereas knockdown of RPL34-AS1 elicited the opposite function. Consistently, overexpression of RPL34-AS1 inhibited tumor growth in vivo. Mechanistically, RPL34-AS1 acted as a competing endogenous RNA (ceRNA) of miR-575 to relieve the repressive effect of miR-575 on its target ACAA2, then suppressed the tumorigenesis of ESCC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results reveal a role for RPL34-AS1 in ESCC tumorigenesis and may provide a strategy for using RPL34-AS1 as a potential biomarker and an effect target for patients with ESCC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-022-10104-6","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T08:03:04Z","timestamp":1664179384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["LncRNA RPL34-AS1 suppresses the proliferation, migration and invasion of esophageal squamous cell carcinoma via targeting miR-575\/ACAA2 axis"],"prefix":"10.1186","volume":"22","author":[{"given":"Hu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enchun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuepu","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,26]]},"reference":[{"key":"10104_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"10104_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115\u201332.","journal-title":"CA Cancer J Clin"},{"key":"10104_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-021-03534-2","volume":"21","author":"J Zhu","year":"2021","unstructured":"Zhu J, Ma SR, Zhou YY, Chen R, Xie SH, Liu ZK, et al. The association between depression and esophageal cancer in China: a multicentre population-based study. Bmc Psychiatry. 2021;21:1.","journal-title":"Bmc Psychiatry"},{"key":"10104_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41389-021-00359-2","volume":"10","author":"ZC Chen","year":"2021","unstructured":"Chen ZC, Huang YW, Hu ZY, Zhao MN, Bian YY, Chen ZW, et al. Dissecting the single-cell transcriptome network in patients with esophageal squamous cell carcinoma receiving operative paclitaxel plus platinum chemotherapy. Oncogenesis. 2021;10:10.","journal-title":"Oncogenesis."},{"key":"10104_CR5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.21147\/j.issn.1000-9604.2021.05.01","volume":"33","author":"J Li","year":"2021","unstructured":"Li J, Xu JG, Zheng YD, Gao Y, He SY, Li H, et al. Esophageal cancer: epidemiology, risk factors and screening. Chinese J Cancer Res. 2021;33:535\u201347.","journal-title":"Chinese J Cancer Res"},{"key":"10104_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.tibs.2018.09.012","volume":"44","author":"X Qian","year":"2019","unstructured":"Qian X, Zhao J, Yeung PY, Zhang QC, Kwok CK. Revealing lncRNA structures and interactions by sequencing-based approaches. Trends Biochem Sci. 2019;44:33\u201352.","journal-title":"Trends Biochem Sci"},{"key":"10104_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1161\/CIRCRESAHA.117.311802","volume":"122","author":"T Sallam","year":"2018","unstructured":"Sallam T, Sandhu J, Tontonoz P. Long noncoding RNA discovery in cardiovascular disease: decoding form to function. Circ Res. 2018;122:155\u201366.","journal-title":"Circ Res"},{"key":"10104_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","volume":"20","author":"M Winkle","year":"2021","unstructured":"Winkle M, El-Daly SM, Fabbri M, Calin GA. Noncoding RNA therapeutics- challenges and potential solutions. Nat Rev Drug Discov. 2021;20:629\u201351.","journal-title":"Nat Rev Drug Discov"},{"key":"10104_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/gcc.22709","volume":"58","author":"L Lorenzi","year":"2019","unstructured":"Lorenzi L, Avila Cobos F, Decock A, Everaert C, Helsmoortel H, Lefever S, et al. Long noncoding RNA expression profiling in cancer: challenges and opportunities. Genes Chromosomes Cancer. 2019;58:191\u20139.","journal-title":"Genes Chromosomes Cancer"},{"key":"10104_CR10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.gene.2019.02.051","volume":"696","author":"W Tian","year":"2019","unstructured":"Tian W, Jiang C, Huang Z, Xu D, Zheng S. Comprehensive analysis of dysregulated lncRNAs, miRNAs and mRNAs with associated ceRNA network in esophageal squamous cell carcinoma. Gene. 2019;696:206\u201318.","journal-title":"Gene."},{"key":"10104_CR11","doi-asserted-by":"publisher","first-page":"681","DOI":"10.7150\/jca.62671","volume":"13","author":"WB Wu","year":"2022","unstructured":"Wu WB, Wei HX, Hu S, Wang Q, Zhang C, Xu J, et al. Long noncoding RNA PCAT6 regulates cell proliferation and migration in human esophageal squamous cell carcinoma. J Cancer. 2022;13:681\u201390.","journal-title":"J Cancer"},{"key":"10104_CR12","doi-asserted-by":"publisher","first-page":"11425","DOI":"10.1080\/21655979.2021.2008759","volume":"12","author":"YL Guo","year":"2021","unstructured":"Guo YL, Sun PP, Guo W, Yin Q, Han JS, Sheng SP, et al. LncRNA DDX11 antisense RNA 1 promotes EMT process of esophageal squamous cell carcinoma by sponging miR-30d-5p to regulate SNAI1\/ZEB2 expression and Wnt\/beta-catenin pathway. Bioengineered. 2021;12:11425\u201340.","journal-title":"Bioengineered."},{"key":"10104_CR13","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41388-021-02073-0","volume":"41","author":"YL Zheng","year":"2022","unstructured":"Zheng YL, Wu JJ, Deng R, Lin CS, Huang YH, Yang X, et al. G3BP2 regulated by the lncRNA LINC01554 facilitates esophageal squamous cell carcinoma metastasis through stabilizing HDGF transcript. Oncogene. 2022;41:515\u201326.","journal-title":"Oncogene."},{"key":"10104_CR14","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.omtn.2020.12.005","volume":"23","author":"YY Zhao","year":"2021","unstructured":"Zhao YY, Yu ZJ, Ma R, Zhang YF, Zhao L, Yan YY, et al. LncRNA-Xist\/miR-101-3p\/KLF6\/C\/EBP alpha axis promotes TAM polarization to regulate cancer cell proliferation and migration. Mol Ther-Nucl Acids. 2021;23:536\u201351.","journal-title":"Mol Ther-Nucl Acids"},{"key":"10104_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/cancers12051245","volume":"12","author":"XZ Zhang","year":"2020","unstructured":"Zhang XZ, Liu H, Chen SR. Mechanisms of long non-coding RNAs in cancers and their dynamic regulations. Cancers. 2020;12:5.","journal-title":"Cancers."},{"key":"10104_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-021-01455-y","volume":"20","author":"YL Jia","year":"2021","unstructured":"Jia YL, Tian C, Wang HY, Yu F, Lv W, Duan YQ, et al. Long non-coding RNA NORAD\/miR-224-3p\/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of beta-catenin. Mol Cancer. 2021;20:1.","journal-title":"Mol Cancer"},{"key":"10104_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3892\/ol.2021.12838","volume":"22","author":"C He","year":"2021","unstructured":"He C, Fu Y, Chen Y, Li XQ. Long non-coding RNA SNHG8 promotes autophagy as a ceRNA to upregulate ATG7 by sponging microRNA-588 in colorectal cancer. Oncol Lett. 2021;22:2.","journal-title":"Oncol Lett"},{"key":"10104_CR18","doi-asserted-by":"publisher","first-page":"6189","DOI":"10.7150\/jca.59337","volume":"12","author":"DZ Zhang","year":"2021","unstructured":"Zhang DZ, Jiang HP, Ye JY, Gao M, Wang XZ, Lu EZ, et al. A novel lncRNA, RPL34-AS1, promotes proliferation and angiogenesis in glioma by regulating VEGFA. J Cancer. 2021;12:6189\u201397.","journal-title":"J Cancer"},{"key":"10104_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-021-02357-1","volume":"21","author":"ZH Zhang","year":"2021","unstructured":"Zhang ZH, Luo YJ, Zhang CQ, Wu P, Zhang GC, Zeng QP, et al. An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer. Cancer Cell Int. 2021;21:1.","journal-title":"Cancer Cell Int"},{"key":"10104_CR20","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1111\/cas.14874","volume":"112","author":"YH Zhu","year":"2021","unstructured":"Zhu YH, Ren CC, Jiang DY, Yang L, Chen YN, Li FY, et al. RPL34-AS1-induced RPL34 inhibits cervical cancer cell tumorigenesis via the MDM2-P53 pathway. Cancer Sci. 2021;112:1811\u201321.","journal-title":"Cancer Sci"},{"key":"10104_CR21","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1002\/jcp.29256","volume":"235","author":"L Ji","year":"2020","unstructured":"Ji L, Fan X, Zhou F, Gu J, Deng X. LncRNA RPL34-AS1 inhibits cell proliferation and invasion while promoting apoptosis by competitively binding miR-3663-3p\/RGS4 in papillary thyroid cancer. J Cell Physiol. 2020;235:3669\u201378.","journal-title":"J Cell Physiol"},{"key":"10104_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.gene.2018.11.008","volume":"687","author":"H Wei","year":"2019","unstructured":"Wei H, Yang ZC, Lin B. Overexpression of long non coding RNA CA3-AS1 suppresses proliferation, invasion and promotes apoptosis via miRNA-93\/PTEN axis in colorectal cancer. Gene. 2019;687:9\u201315.","journal-title":"Gene."},{"key":"10104_CR23","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1080\/15384101.2015.1078034","volume":"14","author":"J Zhao","year":"2015","unstructured":"Zhao J, Liu YC, Zhang WH, Zhou ZW, Wu J, Cui P, et al. Long non-coding RNA Linc00152 is involved in cell cycle arrest, apoptosis, epithelial to mesenchymal transition, cell migration and invasion in gastric cancer. Cell Cycle. 2015;14:3112\u201323.","journal-title":"Cell Cycle"},{"key":"10104_CR24","doi-asserted-by":"publisher","first-page":"109440","DOI":"10.1016\/j.biopha.2019.109440","volume":"120","author":"Z Gong","year":"2019","unstructured":"Gong Z, Li J, Cang P, Jiang H, Liang J, Hou Y. RPL34-AS1 functions AS tumor suppressive lncRNA in esophageal cancer. Biomed Pharmacother. 2019;120:109440.","journal-title":"Biomed Pharmacother"},{"key":"10104_CR25","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41568-021-00353-1","volume":"21","author":"SJ Liu","year":"2021","unstructured":"Liu SJ, Dang HX, Lim DA, Feng FY, Maher CA. Long noncoding RNAs in cancer metastasis. Nat Rev Cancer. 2021;21:446\u201360.","journal-title":"Nat Rev Cancer"},{"key":"10104_CR26","doi-asserted-by":"publisher","first-page":"773864","DOI":"10.3389\/fonc.2021.773864","volume":"11","author":"Y Niu","year":"2021","unstructured":"Niu Y, Wang G, Li Y, Guo W, Guo Y, Dong Z. LncRNA FOXP4-AS1 promotes the progression of esophageal squamous cell carcinoma by interacting with MLL2\/H3K4me3 to upregulate FOXP4. Front Oncol. 2021;11:773864.","journal-title":"Front Oncol"},{"key":"10104_CR27","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1158\/1541-7786.MCR-20-1025","volume":"19","author":"X Liang","year":"2021","unstructured":"Liang X, Lu J, Wu Z, Guo Y, Shen S, Liang J, et al. LINC00239 interacts with C-Myc promoter-binding protein-1 (MBP-1) to promote expression of C-Myc in esophageal squamous cell carcinoma. Mol Cancer Res. 2021;19:1465\u201375.","journal-title":"Mol Cancer Res"},{"key":"10104_CR28","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1158\/0008-5472.CAN-20-1713","volume":"81","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhang W, Liu W, Huang L, Wang Y, Li D, et al. Long noncoding RNA VESTAR regulates lymphangiogenesis and lymph node metastasis of esophageal squamous cell carcinoma by enhancing VEGFC mRNA stability. Cancer Res. 2021;81:3187\u201399.","journal-title":"Cancer Res"},{"key":"10104_CR29","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22:96\u2013118.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10104_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.gene.2018.11.008","volume":"687","author":"H Wei","year":"2019","unstructured":"Wei H, Yang Z, Lin B. Overexpression of long noncoding RNA CA3-AS1 suppresses proliferation, invasion and promotes apoptosis via miRNA-93\/PTEN axis in colorectal cancer. Gene. 2019;687:9\u201315.","journal-title":"Gene."},{"key":"10104_CR31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12943-019-1097-9","volume":"18","author":"YP Hu","year":"2019","unstructured":"Hu YP, Jin YP, Wu XS, Yang Y, Li YS, Li HF, et al. LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p\/SET\/AKT axis. Mol Cancer. 2019;18:167.","journal-title":"Mol Cancer"},{"key":"10104_CR32","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505:344\u201352.","journal-title":"Nature."},{"key":"10104_CR33","first-page":"3993","volume":"14","author":"SQ Xia","year":"2017","unstructured":"Xia SQ, Zhen YH, Ma HS, Wang AM. Abnormal expression of microRNA-575 leads to missed abortion through regulating apoptosis and angiogenesis. Exp Ther Med. 2017;14:3993\u20134000.","journal-title":"Exp Ther Med"},{"key":"10104_CR34","first-page":"2420","volume":"16","author":"XF Zhang","year":"2018","unstructured":"Zhang XF, Xin GD, Sun DJ. Serum exosomal miR-328, miR-575, miR-134 and miR-671-5p as potential biomarkers for the diagnosis of Kawasaki disease and the prediction of therapeutic outcomes of intravenous immunoglobulin therapy. Exp Ther Med. 2018;16:2420\u201332.","journal-title":"Exp Ther Med."},{"key":"10104_CR35","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.febslet.2015.02.013","volume":"589","author":"H Wang","year":"2015","unstructured":"Wang H, Yan C, Shi X, Zheng J, Deng L, Yang L, et al. MicroRNA-575 targets BLID to promote growth and invasion of non-small cell lung cancer cells. FEBS Lett. 2015;589:805\u201311.","journal-title":"FEBS Lett"},{"key":"10104_CR36","doi-asserted-by":"publisher","first-page":"108716","DOI":"10.1016\/j.biopha.2019.108716","volume":"113","author":"YN Wang","year":"2019","unstructured":"Wang YN, Xu F, Zhang P, Wang P, Wei YN, Wu C, et al. MicroRNA-575 regulates development of gastric cancer by targeting PTEN. Biomed Pharmacother. 2019;113:108716.","journal-title":"Biomed Pharmacother"},{"key":"10104_CR37","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.2147\/OTT.S229614","volume":"13","author":"Y Qin","year":"2020","unstructured":"Qin Y, Mi W, Huang C, Li J, Zhang Y, Fu Y. Downregulation of miR-575 inhibits the tumorigenesis of gallbladder Cancer via targeting p27 Kip1. Onco Targets Ther. 2020;13:3667\u201376.","journal-title":"Onco Targets Ther"},{"key":"10104_CR38","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s13046-018-0853-9","volume":"37","author":"S Yan","year":"2018","unstructured":"Yan S, Tang Z, Chen K, Liu Y, Yu G, Chen Q, et al. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression. J Exp Clin Cancer Res. 2018;37:214.","journal-title":"J Exp Clin Cancer Res"},{"key":"10104_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13046-020-01798-2","volume":"40","author":"Y Liu","year":"2021","unstructured":"Liu Y, Liu X, Lin C, Jia X, Zhu H, Song J, et al. Noncoding RNAs regulate alternative splicing in Cancer. J Exp Clin Cancer Res. 2021;40:11.","journal-title":"J Exp Clin Cancer Res"},{"key":"10104_CR40","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1107\/S1399004714023827","volume":"70","author":"TR Kiema","year":"2014","unstructured":"Kiema TR, Harijan RK, Strozyk M, Fukao T, Alexson SEH, Wierenga RK. The crystal structure of human mitochondrial 3-ketoacyl-CoA thiolase (T1): insight into the reaction mechanism of its thiolase and thioesterase activities. Acta Crystallogr D. 2014;70:3212\u201325.","journal-title":"Acta Crystallogr D"},{"issue":"13","key":"10104_CR41","first-page":"2","volume":"78","author":"M Rada","year":"2018","unstructured":"Rada M, Cha J, Sage J, Zhou B, Yang W, Ashkavand Z, et al. Beta-oxidation inhibition as a novel therapy for cisplatin-resistant ovarian cancer. Cancer Res. 2018;78(13):2.","journal-title":"Cancer Res"},{"key":"10104_CR42","doi-asserted-by":"publisher","first-page":"17756","DOI":"10.1021\/acsami.8b05428","volume":"10","author":"Z Shang","year":"2018","unstructured":"Shang Z, Qian LQ, Liu S, Niu XM, Qiao Z, Sun Y, et al. Graphene oxide-facilitated comprehensive analysis of cellular nucleic acid binding proteins for lung Cancer. ACS Appl Mater Interfaces. 2018;10:17756\u201370.","journal-title":"ACS Appl Mater Interfaces"},{"key":"10104_CR43","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1158\/0008-5472.CAN-06-3137","volume":"67","author":"EI Chen","year":"2007","unstructured":"Chen EI, Hewel J, Krueger JS, Tiraby C, Weber MR, Kralli A, et al. Adaptation of energy metabolism in breast cancer brain metastases. Cancer Res. 2007;67:1472\u201386.","journal-title":"Cancer Res"},{"key":"10104_CR44","doi-asserted-by":"publisher","first-page":"633295","DOI":"10.3389\/fgene.2021.633295","volume":"12","author":"F Han","year":"2021","unstructured":"Han F, Zhou L, Zhao L, Wang L, Liu L, Li H, et al. Identification of miRNA in sheep intramuscular fat and the role of miR-193a-5p in proliferation and differentiation of 3T3-L1. Front Genet. 2021;12:633295.","journal-title":"Front Genet"},{"key":"10104_CR45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41598-016-0013-4","volume":"6","author":"JH Xia","year":"2016","unstructured":"Xia JH, Xin LL, Zhu WJ, Li L, Li CX, Wang YF, et al. Characterization of long non-coding RNA transcriptome in high-energy diet induced nonalcoholic steatohepatitis minipigs. Sci Rep-Uk. 2016;6:11.","journal-title":"Sci Rep-Uk"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-10104-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-022-10104-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-10104-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T09:11:01Z","timestamp":1664183461000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-022-10104-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,26]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["10104"],"URL":"https:\/\/doi.org\/10.1186\/s12885-022-10104-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,26]]},"assertion":[{"value":"20 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Southeast University Affiliated Zhongda Hospital Ethics Committee, and it was conducted in compliance with the Helsinki Declaration. All of the informed consent was obtained from the eligible participants. In addition, all the animal procedures were performed according to the National Institutes of Health Guide for the care and approved by the Animal Care and Use Committee of Southeast University, and the study was carried out in compliance with the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1017"}}